Kinfo
Regentis Biomaterials Ltd. logo

Regentis Biomaterials Ltd.

RGNTNYSEHealthcare·US · USD
$1.27
+0.08 (+6.72%)
Prices as of November 9, 2026 · market closed

Price

Key statistics

Valuation
Market cap8.92M USD
Enterprise value-564.53K USD
Trailing P/E0.00
Forward P/E0.00
PEG ratio0.00
Price / sales0.00
Price / book1.09
Profitability
Gross margin0.00%
Operating margin0.00%
Profit margin0.00%
Return on assets-113.59%
Return on equity-288.62%
Income (TTM)
Revenue0.00 USD
Gross profit0.00 USD
EBITDA0.00 USD
Net income-16.10M USD
Diluted EPS-$2.46
Rev. growth (YoY)0.00%
Balance sheet
Total cash8.95M USD
Total debt29.00K USD
Debt / equity0.38
Current ratio5.62
Book value / share$1.09
Cash flow (TTM)
Operating cash flow-3.84M USD
Levered free cash flow2.14M USD
Shares & price
Shares outstanding5.18M
Float4.26M
Held by institutions24.79%
Beta0.00
50-day MA$1.70
200-day MA$2.77
52-week high$15.50
52-week low$1.16
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-04-293.694.10+11.11%2026-04-130.300.30+0.00%2026-01-231.611.87+16.15%
About Regentis Biomaterials Ltd.

Regentis Biomaterials Ltd. is a regenerative medicine company focused on developing and commercializing tissue repair solutions for damaged cartilage, bone, and other tissues. The company’s core platform, Gelrin, uses degradable hydrogel implants designed to support the regeneration of diseased or injured tissue, with a particular emphasis on orthopedic applications. Its lead product, GelrinC, is a cell-free, off-the-shelf hydrogel implant intended for knee cartilage repair, making it relevant to sports medicine and early-stage osteoarthritis care. Regentis Biomaterials serves the broader healthcare and biomedical device markets through products aimed at restoring tissue function and improving patient outcomes. The company is headquartered in Herzliya, Israel.

Sector
Healthcare
Industry
Medical Instruments & Supplies
CEO
Dr. Ehud Geller Ph.D.
Employees
3
Headquarters
Herzliya, Israel

Frequently asked questions about Regentis Biomaterials Ltd.